Ablation of neurons expressing agouti-related protein activates fos and gliosis in postsynaptic target regions.
We have developed a mouse model in which a specific population of inhibitory neurons can be selectively ablated by the action of diphtheria toxin (DT). The model involves targeting the human DT receptor to the agouti-related protein (Agrp) locus so that systemic administration of DT kills all of the AgRP-expressing neurons, resulting in starvation of the mice. Ablation of AgRP neurons results in robust (5- to 10-fold) activation of Fos gene expression in many brain regions that are innervated by AgRP neurons, including the arcuate nucleus (ARC), the paraventricular nucleus, the medial preoptic area, the lateral septum, and nucleus of the solitary tract. As expected, there is robust increase in GFAP staining (astrocytes) as well as IBA1 and CD11b staining (microglia) in the ARC in response to AgRP neuron ablation. There is also a dramatic increase of these markers in most, but not all, postsynaptic targets of AgRP axons. We used a genetic approach to reduce melanocortin signaling, which attenuated Fos activation in some brain regions after ablation of AgRP neurons. We suggest that loss of inhibitory signaling onto target neurons results in unopposed excitation that is responsible for the activation of Fos and that dysregulation of these neuronal circuits is responsible for starvation. Furthermore, glial cell activation in target areas of AgRP neurons appears to be a result of excitotoxicity.
Wu
Qi
Q
Howard Hughes Medical Institute, University of Washington, Seattle, Washington 98195, USA.
Howell
Maureen P
MP
Palmiter
Richard D
RD
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D054369:Agouti-Related Protein / Q000235:genetics / Q000378:metabolism*; D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000166:cytology*; D039481:CD11b Antigen / Q000235:genetics / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects; D004167:Diphtheria Toxin / Q000633:toxicity; D005786:Gene Expression Regulation / Q000187:drug effects; D005904:Glial Fibrillary Acidic Protein / Q000235:genetics / Q000378:metabolism; D005911:Gliosis / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D066257:Heparin-binding EGF-like Growth Factor; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D008840:Microfilament Proteins; D009474:Neurons / Q000187:drug effects / Q000473:pathology*; D010455:Peptides / Q000378:metabolism; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D011042:Poisons / Q000633:toxicity; D011333:Pro-Opiomelanocortin / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology / Q000528:radiation effects; D013569:Synapses / Q000187:drug effects / Q000473:pathology*
D054369:Agouti-Related Protein; C515199:Agrp protein, mouse; C491049:Aif1 protein, mouse; D039481:CD11b Antigen; D002135:Calcium-Binding Proteins; D004167:Diphtheria Toxin; D005904:Glial Fibrillary Acidic Protein; C587883:HBEGF protein, human; C587884:Hbegf protein, mouse; D066257:Heparin-binding EGF-like Growth Factor; D036341:Intercellular Signaling Peptides and Proteins; C484883:MCR 4 peptide; D008840:Microfilament Proteins; D010455:Peptides; D011042:Poisons; D016760:Proto-Oncogene Proteins c-fos; D011333:Pro-Opiomelanocortin; D000324:Adrenocorticotropic Hormone; D010751:Phosphopyruvate Hydratase
Annu Rev Pharmacol Toxicol. 2007;47:117-41
16879082
Science. 2002 Oct 18;298(5593):556-62
12386325
Endocrinology. 1999 Mar;140(3):1408-15
10067869
J Cell Biol. 1979 Apr;81(1):50-8
225334
Science. 2005 Mar 25;307(5717):1909-14
15790843
Bacteriol Rev. 1975 Mar;39(1):54-85
164179
Neurobiol Dis. 2007 Jan;25(1):150-62
17046272
Nat Med. 1998 Jun;4(6):722-6
9623984
Neuron. 2001 May;30(2):345-54
11394998
Endocrinology. 2008 Feb;149(2):544-50
17974621
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2687-92
18272480
Nat Med. 1998 Jun;4(6):718-21
9623983
Trends Neurosci. 1999 Jan;22(1):25-30
10088996
Glia. 2006 Jan 15;53(2):212-24
16206168
Brain Res Brain Res Rev. 2005 Apr;48(2):196-206
15850658
J Neurosci. 2006 Jun 28;26(26):7116-20
16807340
Nat Neurosci. 2007 Nov;10(11):1387-94
17965659
Proc Natl Acad Sci U S A. 1978 Dec;75(12):6300-4
366617
Epilepsy Res. 2000 Apr;39(2):153-69
10759303
Nature. 2007 Jan 11;445(7124):168-76
17151600
Cell. 2005 Nov 4;123(3):493-505
16269339
Science. 2005 Oct 28;310(5748):683-5
16254186
Genes Dev. 1993 Jul;7(7A):1203-13
8319910
J Neuroimmune Pharmacol. 2006 Jun;1(2):127-37
18040779
Nat Neurosci. 2005 May;8(5):571-8
15856065
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15043-8
9844012
Brain Res Brain Res Rev. 1999 Jul;30(1):77-105
10407127
Endocrinology. 2006 Oct;147(10):4542-9
16709610
Obesity (Silver Spring). 2006 Aug;14 Suppl 5:216S-221S
17021370
Nat Neurosci. 2005 Oct;8(10):1289-91
16158063
Nature. 1978 Sep 21;275(5677):226-8
211426
Front Neuroendocrinol. 2002 Jan;23(1):2-40
11906202
Nature. 2001 May 24;411(6836):480-4
11373681
Peptides. 2007 Feb;28(2):214-25
17194499